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Abstract
Background: Herpes simplex virus infections are highly prevalent in humans. However, the current therapeutics suffer
important drawbacks such as limited results in neonates, increasing occurrence of resistance and impeded treatment of
stromal infections. Remarkably, interactions of herpesviruses with human mucosa, the locus of infection, remain poorly
understood and the underlying mechanisms in stromal infection remain controversial.
Methodology/Principal Findings: A human model consisting of nasal respiratory mucosa explants was characterised.
Viability and integrity were examined during 96 h of cultivation. HSV1-mucosa interactions were analysed. In particular, we
investigated whether HSV1 is able to reach the stroma. Explant viability and integrity remained preserved. HSV1 induced
rounding up and loosening of epithelial cells with very few apoptotic and necrotic cells observed. Following 16–24 h of
infection, HSV1 penetrated the basement membrane and replicated in the underlying lamina propria.
Conclusions/Significance: This human explant model can be used to study virus-mucosa interactions and viral mucosal
invasion mechanisms. Using this model, our results provide a novel insight into the HSV1 stromal invasion mechanism and
for the first time directly demonstrate that HSV1 can penetrate the basement membrane.
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Introduction
Alphaherpesviruses constitute the largest subfamily of the
Herpesviridae and consist of closely related pathogens of man and
animals. The human alphaherpesviruses are comprised of the two
antigenically distinct herpes simplex viruses type 1 (HSV1) and
type 2 (HSV2) and varicella-zoster virus (VZV). HSV is a clinically
important pathogen where HSV1 generally causes oral blisters
and HSV2 causes genital ulcers. Historically, HSV1 was found
infrequently in genital HSV infections, but recent studies show an
increasing prevalence up to 60%, possibly associated with
increasing orogenital contact, highlighting the importance of
HSV1 in human health [1,2]. HSV infections may also lead to
ocular herpes with symptoms varying from mild to severe stromal
keratitis. Epithelial keratitis progresses to stromal keratitis in 25%
of cases, which may result in loss of sight and blindness, and
recurrent ocular HSV1 infections remain the major cause of viral
induced blindness. HSV infection can also cause encephalitis,
aseptic meningitis and atypical pneumonia [1,3].
The prevalence of antibodies to HSV1 in the adult population
ranges between 52 and 84% and reaches approximately 90% in
European countries and in the United States respectively whereas
respectively 4 to 24% and 22% of the European and American
adult population is seropositive for HSV2 [4–6], with many
patients suffering recurrent symptoms upon reactivation of the
virus [7].
The current therapeutics against herpesviruses face a number of
important drawbacks. The therapeutic benefit of acyclovir
treatment for encephalitis is limited, where the mortality in
newborns remains high at 15%, where only 29% of neonatal
survivors show normal development following resolution of
infection [8,9]. An increasing problem is the occurrence of
resistance to acyclovir and derivatives which threatens the
effectiveness of the drugs and reduces the likelihood of favourable
outcomes [10–12]. An alternative therapeutic option for treatment
of stromal keratitis is hampered by a lack of knowledge concerning
the mechanism by which the virus reaches the stroma through the
basement membrane (BM) [7,10–13]. These problems highlight
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22160an unmet medical need for improved or novel therapeutic options
for HSV infection.
The respiratory portion of the nasal cavities is lined by a
pseudostratified ciliated epithelium with goblet cells supported by
the lamina propria, consisting of connective tissue with seromu-
cous glands and a rich venous plexus. The lamina propria is
continuous with the periosteum or perichondrium of bone or
cartilage respectively, which form the wall of the nasal cavities.
The BM is a layered structure of extracellular matrix which
separates cells from the surrounding lamina propria and which
provides a structural support for most epithelia. The structure is
organised by glycoproteins and proteoglycans, of which the main
components are laminins, type IV collagens, nidogens and
heparan sulphate proteoglycans. The BM consists of two layers,
the basal lamina (lamina densa) and reticular lamina (lamina
reticularis or fibroreticularis). The lamina densa consists of
laminin, type IV collagen, entactin and proteoglycans and is in
direct contact with epithelial cell surfaces. The lamina reticularis
consists of type III collagens, called reticular fibers, supports the
lamina densa and forms the connection with the lamina propria
[14–16].
The literature concerning HSV penetration of the mucosal BM
is ambiguous at best, where most previous HSV-mucosal studies
focussed on quantification of viral production in nasal swabs. Patel
et al. [17–18] performed a histopathologic study of the depth of
herpetic human skin lesions and observed that HSV causes lesions
extending through the BM. However, no immunohistochemical
detection of viral antigens was performed, preventing determina-
tion of whether the virus crossed the BM. Furthermore, it remains
elusive whether the inflammatory infiltrate plays a role either in
preventing virus spread or in damaging the surrounding tissue,
including the BM. Herpes stromal keratitis has been reported both
in humans and animals [19–20]. In mice, it has been stated that
herpetic stromal keratitis appeared to be an immunopathogenic
disease, rather than a result from direct viral replication; albeit
with potential roles of viral factors. Nevertheless, the relationship
epithelial-stromal disease remained unclear [20]. More recently,
researchers from the same group demonstrated small amounts of
HSV antigens in the stroma. How these antigens reached the
stroma to cause stromal keratitis remained an open question [21].
Weeks et al. [22] defined the BM as a barrier to HSV and
postulated that virus reaches the lamina propria via free nerve
endings above the BM based on intradermal injections of HSV
below the BM in mice, with no disease in 4 out of five animals.
The authors also demonstrated that HSV1 was unable to pass
through a reconstituted BM; results that are at variance with
commonly observed HSV viremia during primary genital infection
[23]. Furthermore, Berrington et al. [24] detected HSV DNA in
peripheral blood, visceral organs and body cavities, albeit without
viral culture studies to prove the presence of viable virus.
However, samples were resistent to DNAase digestion, suggesting
that the DNA was contained within virions. Also, to reach
peripheral blood, virus must breach the BM. Additionally, several
research groups demonstrated HSV particles in human corneal
stroma [19]. However, whether the virus can actively penetrate
the BM or relies on BM-damaging lesions to do so, remains
unclear.
Whereas for animal herpesviruses, nasal mucosa is considered
the primary site of replication, to our knowledge, the role of
human nasal mucosa in primary HSV infection is unknown. First,
it is impossible to study primary viral replication in humans during
a challenge experiment. Secondly, studies of anatomical sites of
HSV are to our knowledge restricted to one study on human
cadavers at autopsy which identified the nasal mucosa as one
reservoir of infection [25], implying a potential role for nasal
mucosa in the herpesvirus life cycle.
In the present study, a human mucosa model consisting of nasal
respiratory explants was characterised into detail. Successful
explant models should retain viability, integrity and normal
morphology for up to 4 days post cultivation to allow viral
invasion experiments. Besides the general interest and potential of
human explant models, the model can be used to study HSV1-
nasal respiratory mucosa interactions. In this study, we address the
controversial question of whether HSV1 is able to penetrate the
BM. We determined the kinetics of HSV1 spread in human nasal
respiratory mucosa in 3-dimensions and demonstrated that HSV1
penetrated the BM in human nasal respiratory mucosa, repre-
senting a significant novel insight into the pathogenesis of HSV1.
Methods
The human nasal respiratory mucosa explant model
Preparation, isolation and cultivation of human nasal
respiratory explants. Human nasal mucosa from lower
turbinate (concha nasalis inferior) was obtained at the time of
surgical treatment of 3 persons with septal deviations and
otherwise healthy nasal mucosa in the university hospital
UZGent. All persons provided written informed consent and the
ethics committee of the Ghent University Hospital approved the
study.
Tissues were transported in phosphate buffered saline (PBS),
supplemented with 1 mg/ml streptomycin (Certa), 1000 U/ml
penicillin (Continental Pharma), 1 mg/ml kanamycin (Sigma) and
5 mg/ml fungizone (Bristol-Myers Squibb). Sections of mucosa of
16 mm
2 were excised and placed with epithelial surface upwards
on fine-meshed gauze for culture at an air-liquid interface at 37uC
and 5% CO2, maintained with serum-free medium (50% RPMI
(Gibco)/50% DMEM (Gibco) supplemented with 0.3 mg/ml
glutamin (BDH Biochemical), 1 mg/ml gentamycin (Gibco),
0.1 mg/ml streptomycin (Certa) and 100 U/ml penicillin (Conti-
nental Pharma)). During the cultivation period, medium was not
replaced.
Explants were collected for morphometric and viability analysis
at 0, 24, 48, 72 and 96 h of cultivation of triplicate independent
experiments.
Analysis of viability - TUNEL assay
DNA fragmentation was detected using the In Situ Cell Death
Detection Kit (TUNEL reaction) (Roche). Samples were analysed
with a Leica DM RBE fluorescence microscope (Leica Micro-
systems GmbH). TUNEL-positive cells were counted in five
randomly selected fields of 100 cells of both epithelium and lamina
propria (Table 1).
Table 1. Occurrence of apoptosis in the epithelium and
lamina propria in human nasal respiratory explants during in
vitro cultivation.
% TUNEL-positive cells at … h of in vitro cultivation
0 2 44 87 29 6
Epithelium 0.760.4 0.560.4 0.660.5 1.161.0 0.460.2
Lamina
propria
2.161.8 1.161.3 2.561.3 2.361.4 1.460.9
doi:10.1371/journal.pone.0022160.t001
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technique and FITC dextran Functional integrity of the tissue was
investigated before cultivation and at the end of the 96 h
cultivation period at air-liquid interface on the gauze. To this
end, explants were mounted in Ussing chambers at 0 h of in vitro
cultivation (immediately after sampling) and after 96 h of in vitro
cultivation and the potential difference (PD, mV) and
transmucosal electrical resistance (R, V.cm
2) were monitored.
PD reflects the integrity of the cell membrane and the activity of
the ion pumps. R reflects the integrity of the tight junctions. A
decrease in resistance may indicate damage to the mucosa. Tight
junctions restrict in a selective manner paracellular diffusion of
ions and noncharged solutes. Therefore, in addition to the
measurement of R to determine ion permeability, fluorescently
labeled dextran, 4 kDa FITC dextran, was used to monitor
permeability of noncharged solutes, to fully characterise the
functional state of the tight junctions [26–27]. For the Ussing
chamber set up, four Ag/AgCl electrodes were connected on one
side to each chamber by 3 M KCl-agar bridges and on the other
side to an external six-channel microcomputer-controlled voltage/
current clamp. R was determined from voltage deflections in
response to bipolar 50 mA current pulses generated for 200 ms and
subsequently calculated from Ohm’s law using the software
package Clamp version 2.14 (Mubler Scientific Instruments).
Data were corrected for the offset potential and resistance of the
buffer solution (the cultivation medium), determined prior to the
experiments. The fluorescently labelled dextran 1 mg/ml solution
was added to the mucosal compartment at the beginning of the
Ussing chamber experiment. Hundred ml samples were taken from
the mucosal and submucosal compartment to determine the initial
concentrations, at 0 h of the Ussing chamber experiment. Two h
after adding the FITC dextran to the mucosal compartment,
100 ml samples were taken from both compartments to determine
tight junction leakage. Fluorescence (optical density) was measured
at each sampling point using a Fluoroskan Ascent FL fluorometer
(Thermo Labsystems) with lexc 495 nm and lem 521 nm (Table 2).
Morphometric analysis - Light microscopy
Explants were fixed and stained as described previously [28].
A haematoxylin-eosin staining was used to estimate the
epithelial thickness at different time points of in vitro cultivation.
As such, epithelial morphometry was evaluated for abnormalities
(cell separation and extrusion, cell number, cell swelling). A
reticulin staining was performed to visualise collagen type III
reticular fibers, which are present in the lamina reticularis of the
BM [29]. The reticular fibers (or reticulin) is a histological term
used to describe a type of fibers in connective tissue composed of
type III collagen [15,30]. As such, type III collagen fibers or
reticular fibers are not only part of the lamina reticularis of the
BM, but also of the lamina propria. However, a higher
concentration of type III collagen fibers forms a dense layer,
which is defined as the lamina reticularis (marked with a white
arrow in Figure 1). Using this stain, the thickness of the lamina
reticularis was measured and as such, its continuity was evaluated
during cultivation. The epithelial thickness and the thickness of the
lamina reticularis were measured at five randomly selected places
in five randomly chosen field. The Van Gieson staining marks all
types of collagen, especially collagen type I [31] and was used to
analyse the integrity of the lamina propria. Using the Soft Imaging
System analySISH, relative amounts of collagen and nuclei were
calculated in a defined region of interest (roi) in five randomly
selected fields by setting a threshold. All samples were analysed
with an Olympus BX61 light microscope at magnification 640
using the Soft Imaging System Cell
F (Olympus) (Figure 1 and
Figure 2).
Morphometric analysis - Transmission electron
microscopy
Fixation and embedding were performed as descibed previously
[28]. Stained ultrathin sections were analysed using a JEM-1010
transmission electron microscope (Jeol Ltd.). The continuity of the
lamina densa was visualised using transmission electron micros-
copy (Figure 3).
Interactions between HSV1 and human nasal respiratory
mucosa
Virus strain and inoculation procedure. HSV1 (ATCC
VR-733) virus stocks were grown on Vero cells (ATCC CCL-81).
Explants were inoculated immediately after cultivation. There-
fore, explants were placed at the bottom of a 24-well plate with
epithelial surface upwards, washed twice with warm serum-free
medium and inoculated by adding 1 ml virus suspension
containing 10
7 TCID50 HSV1/ml, which was obtained by
diluting virus stock in serum-free explant cultivation medium to
final concentrations of 10
7 TCID50/ml (1 h, 37uC, 5% CO2). One
h after inoculation, explants were washed three times and
transferred again to the gauze. At 0, 12, 16, 20, 24 and 36 h
post inoculation (pi), samples were collected, embedded in
methocelH (Fluka) and frozen at 270uC. Explants of 3 different
persons were included.
Evaluation of HSV1 mucosal spread - Immunofluorescence
staining. Cryosections (20 mm) were made, fixed in methanol
(220uC, 100%, 25 min) and stained for HSV1 antigens and
collagen IV to enable discrimination of the BM from the overlying
epithelium. Cryosections were incubated (1 h, 37uC) with goat anti-
collagen IV antibodies (Southern Biotech) (1:50 in PBS), washed
three times (PBS), incubated (1 h, 37uC) with biotinylated rabbit
anti-goat IgG antibodies (Sigma) (1:100 in PBS), washed three times
Table 2. Fluorescence intensity of mucosal and submucosal compartment using FITC dextran as a molecular marker for tight
junction damage.
Fluorescence intensity
Mucosal compartment Submucosal compartment
0 h in vitro cultivation 0 h after adding FITC dextran 595.3625.7 0.560.1
2 h after adding FITC dextran 559.1631.9 0.560.0
96 h in vitro cultivation 0 h after adding FITC dextran 553.8651.6 0.560.0
2 h after adding FITC dextran 565.3632.8 0.560.0
doi:10.1371/journal.pone.0022160.t002
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(Molecular Probes) (1:50 in PBS). Subsequently, explants were
incubated with 10% NGS (10 min, RT). HSV1-infected cells were
detected by incubating (1 h, 37uC) the sections with mouse
monoclonal anti-HSV1 gD antibodies (Santa Cruz Biotechnology)
(1:100 in 10% NGS), washing three times (PBS) and incubating (1 h,
37uC) with FITC-labelled goat anti-mouse antibodies (Molecular
Probes) (1:100 in 10% NGS). Finally, cryosections were washed
three times (PBS) and mounted with glycerin-DABCO.
Evaluation of HSV1 mucosal spread - Confocal micro-
scopy. Immunofluorescence image series of stained cryosections
were acquired with a Leica TCS SP2 confocal microscope (Leica
Microsystems GmbH). A Gre/Ne 543 nm and Argon 488 nm
laser were used to excite respectively Texas Red- and FITC-
fluorophores.
Evaluation of HSV1 mucosal spread - Plaque analysis.
Plaque dimensions, latitude and penetration depth underneath the
BM (distance covered by HSV1 in the lamina propria), were
measured at maximal size for 10 different plaques per person at 0,
12, 16, 20, 24 and 36 h pi using the software imaging system
ImageJ (Figure 4).
In addition, HSV1 mucosal invasion in the depth was graded on
a 6-point scale (Figure 5). Analysis of the depth of HSV1 mucosal
invasion (vertical spread perpendicular to the BM) was based on
scoring the infected area, as follows: 0=epithelium not infected,
1=columnar cell(s) infected, 2=suprabasal cell(s) infected,
3=basal cell(s) infected, 4=BM and HSV1 colocalisation,
HSV1 does not cross the BM, 5=HSV1 penetrates the BM into
the lamina propria.
Epithelial damage in HSV1-infected human nasal res-
piratory mucosa. The epithelial damage of the immunofluo-
rescence stained sections was assessed in 10 different populations
of HSV1-negative and HSV1-positive cells, in extenso virus
plaques at maximal size, per person at 0, 12, 16, 20, 24 and 36 h
pi. Epithelial damage was graded on a 4-point scale (Figure 5).
Cell survival in HSV1-infected human nasal respiratory
mucosa. For detection of HSV1 antigens, immunofluorescence
stainings were performed as described above. The TUNEL assay
(Roche) was performed to detect DNA fragmentation. The
fluorescent nucleic acid dye, ethidium monoazide bromide
(EMA, Invitrogen), selectively staining DNA in cells with a
disrupted plasma membrane, was used at a concentration of
0.05 mg/ml as a marker for necrosis and late stages of apoptosis
[32–33]. TUNEL- and EMA-positive cells were counted in regions
containing HSV1-negative cells or HSV1-positive cells (virus
plaque) at 0, 12, 24 and 36 h pi per person. For HSV1-negative
cells, 10 randomly selected regions of 100 cells were evaluated for
both epithelium and lamina propria. For HSV1-positive cells, 10
randomly selected HSV1 plaques were evaluated in both
epithelium and lamina propria. Experiments were performed in
triplicate.
Statistical analysis
Data were statistically evaluated by SPSS software (SPSS Inc.)
for analysis of variance (ANOVA). Results with P values of #0.05
were considered significant. Data shown represent means+SD of
triplicate independent experiments.
Results
The human nasal respiratory mucosa explant model
Viability of epithelium and lamina propria. The effect of
cultivation on the viability of the explants was verified by
quantification of the percentage apoptotic cells in both
epithelium and lamina propria at 0, 24, 48, 72 and 96 h of in
vitro cultivation (Table 1). No significant differences were observed
throughout cultivation. The percentage TUNEL-positive cells in
epithelium and lamina propria ranged from 0.4 to 1.1% and from
1.1 to 2.5% respectively.
By using the Ussing chamber technique and FITC dextran, the
maintenance of functional integrity of the explants during
cultivation was verified. Mean changes 6 SD in R and PD of
triplicate independent experiments before and after 96 h of in
Figure 1. Light photomicrographs of the human model. Representative light photomicrographs of human nasal respiratory mucosa explants
at 0 (A, B, C) and 96 h (D, E, F) of in vitro cultivation are illustrated. Light microscopical morphometric analysis was performed to evaluate the
maintenance of structural integrity of the explants during in vitro cultivation. The three-dimensional organization of the explants was assessed by
evaluating the morphometry of the epithelium, lamina reticularis and lamina propria. Eight-micron-sections were stained with haematoxylin-eosin( A
and D) for evaluation of the epithelial thickness (indicated by black arrows). A reticulin staining (B and E) was performed to measure the thickness of
the lamina reticularis (indicated by white arrows). A Van Gieson staining (C and F) was used to count the relative amounts of collagen and nuclei
within a region of interest (roi indicated by a rectangle) of the lamina propria. By setting a threshold, different colors were assigned to collagen and
nuclei, respectively, and the percentages of collagen and nuclei were determined within this roi. Bar, 50 mm.
doi:10.1371/journal.pone.0022160.g001
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technique. We obtained a modest decline in R over time with a
mean value of 377.7612.5 V.cm
2 before cultivation and a mean
value of 315.3612.7 V.cm
2 after 96 h of in vitro cultivation.
Mean PD values did not decrease with time of in vitro cultivation.
We obtained a mean PD value of 21.263.1 mV and
20.260.6 mV before and after cultivation respectively. Using
FITC dextran as a molecular marker of tight junction intact
functionality, no time-dependent increase in the fluorescence
intensity values of the submucosal compartment (Table 2) was
measured after 96 h of in vitro cultivation.
Epithelial morphometry. No significant differences in
epithelial thickness were observed over time. Representative
images of epithelial thickness at 0 and 96 h of in vitro culture
are illustrated in Figure 1a and 1d. Quantification is shown in
Figure 2a.
Basement membrane morphometry. Two layers are
present within the BM: lamina reticularis and lamina densa
[34]. Therefore, morphometry of the BM was evaluated by
measuring thickness of the lamina reticularis using light
microscopy and by evaluating integrity of the lamina densa
using transmission electron microscopy at specific time points post-
sampling. No significant changes were observed in thickness of the
lamina reticularis during the cultivation period (Figure 2b).
Representative images of the lamina reticularis at 0 and 96 h
post-sampling are illustrated in Figure 1b and 1e. The lamina
densa remained continuous throughout cultivation (Figure 3).
Morphometry of the lamina propria. Integrity and
composition of the lamina propria were evaluated using a Van
Gieson staining (Figure 1c and 1f). No significant differences were
observed in relative amounts of collagen and nuclei over time
(Figure 2c).
Interactions between HSV1 and human nasal respiratory
mucosa
Evaluation of HSV1 mucosal spread. Inoculation of
human nasal respiratory explants with HSV1 resulted in the
occurrence of virus plaques. Kinetics of viral mucosal invasion
were evaluated by measuring maximal plaque latitude and
penetration depth underneath the BM at 0, 12, 16, 20, 24 and
36 h pi. Mean values+SD of three independent experiments are
represented in Figure 4a. Plaque latitudes increased steadily over
time, from 0.0 mm at 0 h pi to 17.7, 55.3, 122.9, 163.2 and
311.1 mm at 12, 16, 20, 24 and 36 h pi, respectively. Remarkably,
HSV1 penetrated the BM rapidly where virus plaques crossed the
BM from 16 h pi onwards and virus plaque size underneath the
BM increased steadily from 0.0 mm at 0 h pi to 0.0, 1.8, 7.5, 20.8
and 36.2 mm at 12, 16, 20, 24 and 36 h pi, respectively. The depth
of HSV1 mucosal invasion is illustrated in Figure 5.
Representative confocal photomicrographs of plaque formation
are illustrated in Figure 4b. About 20% of the viral plaques
breached the BM at 16 h pi, increasing to 50% at 20 h pi and
reaching 100% at 24 h pi demonstrating rapid penetration of the
protective lamina by HSV1.
Epithelial damage in HSV1-infected human nasal
respiratory mucosa. Comparisons of epithelial damage
revealed aggravated epithelial damage and loosening of
epithelial cells in HSV1-infected epithelium compared with
baseline damage scores of regions of non-infected cells with
increasing time pi (Figure 5 and illustrations Figure 4b).
Cell survival in HSV1-infected human nasal respiratory
mucosa. After inoculation with HSV1, a large number of cells
were HSV1-positive, where a minority of either HSV1-infected or
non-infected cells were TUNEL- or EMA-positive (Table 3 and 4
respectively).
Discussion
Interactions of herpesviruses with mucosa remain poorly
understood with a sparse knowledge of stromal invasion.
Therefore, investigation of the mucosal invasion mechanism of
alphaherpesviruses is pivotal in delivering new insights into the
Figure 2. Morphometric evaluation of the human model.
Maintenance of the structural integrity of the explants during in vitro
cultivation was evaluated by assessing the three-dimensional organi-
zation of the explants. Epithelial thickness (A), thickness of the lamina
reticularis (B) and percentages of nuclei and collagen within a region of
interest of the lamina propria (C) were evaluated in explants at different
time points of in vitro cultivation. Data are represented as means+SD
(error bars) of triplicate independent experiments.
doi:10.1371/journal.pone.0022160.g002
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therapeutic options.
So far, herpesvirus-mucosa interactions have been mainly
studied in non-homologous animal models. In the current study,
a homologous human explant model was used. In order to
investigate mucosal invasion mechanisms of viruses, it is vital that
the morphology and viability of the different tissue layers in the
explant are maintained throughout the cultivation period. Explant
Figure 3. Transmission electron photomicrographs of the human model. The continuity of the lamina densa was evaluated during in vitro
cultivation to assess the structural integrity of this basement membrane layer. The photomicrographs show representative images of the intact
lamina densa in human nasal respiratory explants at 0 (A) and 96 (B) h of in vitro cultivation. Arrows indicate the lamina densa.
doi:10.1371/journal.pone.0022160.g003
Figure 4. Evolution of HSV1 mucosal spread. (A) Kinetic evolution of HSV1 plaque formation. Explants were inoculated with 1 ml virus
suspension containing 10
7 TCID50/ml HSV1 VR-733 and sampled at 0, 12, 16, 20, 24 and 36 h post inoculation (pi). Serial 20 mm cryosections were
made and plaque latitude (white bars) and plaque depth underneath the basement membrane (BM), distance covered by HSV1 in the lamina propria,
(black bars) were measured using ImageJ. Data are represented as means of 10 plaques of triplicate independent experiments+SD (error bars).
*, Significant differences at the 0.05 level. (B) Representative confocal photomicrographs of the evolution of HSV1 VR-733 spread in human nasal
respiratory explants at 0, 12, 16, 20, 24 and 36 h pi. Collagen IV is visualised by red fluorescence. Green fluorescence visualises HSV1 antigens. Bar,
100 mm. Abbreviations: Ep, epithelium; LP, lamina propria. The BM is marked with a dashed line.
doi:10.1371/journal.pone.0022160.g004
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[35–38], where only Jackson et al. [37] performed a morphometric
and viability analysis, albeit with no evaluation of the morphom-
etry of the BM or viability and integrity of the lamina propria,
both crucial factors when studying mucosal invasion through the
BM. Where previous studies focused on epithelial cell viability and
integrity, our study underscores the importance of an examination
of the integrity and viability of both epithelium and lamina propria
and of the examination of the continuity of the BM barrier.
A human nasal respiratory explant model was characterised
analogous to a porcine nasal respiratory explant model that we
reported recently [28]. Normal epithelial function depends upon
the retention of cell junctions, the polarity of the epithelium and
the orientation of the epithelium on the connective tissue
substratum. Tissue function is maintained by normally constant
architectural relationships. Loss of this three-dimensional organi-
zation can affect secretion and other physiologic responses [37].
The presence of BMs is a pre-requisite for most tissues to function
properly as BMs have the capability to influence various activities
of surrounding cells and may alter intercellular and cell-matrix
junctions [14,39]. Therefore, integrity and viability of both
epithelium and lamina propria as well as BM integrity were
evaluated. The structural integrity was evaluated by assessment of
the three-dimensional organization. Thickness of epithelium and
lamina reticularis, continuity of lamina densa and relative amounts
of collagen and nuclei remained similar throughout the cultivation
period. Viability and functional integrity of the explants were
evaluated in both epithelium and lamina propria by quantifying
DNA fragmentation (TUNEL assay) at 0, 24, 48, 72 and 96 h of in
vitro cultivation, by quantifying plasma membrane permeability
(EMA staining) at 0 and 36 h of cultivation, by performing the
Ussing technique and using FITC dextran as a marker for tight
junction leakage. In both epithelium and lamina propria, the
percentage TUNEL or EMA-positive cells remained below 2.5
and 0.7% respectively. Using the Ussing chamber technique, we
obtained a modest decline in R over time with a mean value of
377.7612.5 V.cm
2 before cultivation and a mean value of
315.3612.7 V.cm
2 after 96 h of in vitro cultivation. Mean PD
values did not decrease with time of in vitro cultivation. We
obtained a mean PD value of 21.263.1 mV and 20.260.6 mV
before and after cultivation respectively. These values are largely
in line with previously reported bioelectric properties of human
nasal mucosal tissue or cultured human nasal epithelial cells. R
values of 6656124 V.cm
2 and 187624 V.cm
2 were acquired for
human nasal epithelial cell monolayers obtained from healthy
individuals undergoing corrective surgery of the nasal septum [40]
and from individuals undergoing surgery for symptomatic nasal
obstruction caused by nonatopic or allergic rhinosinusitis [41]
respectively. PD values of 2662 mV were shown for normal
human nasal turbinate tissue obtained from individuals with
healthy mucosa undergoing reconstructive surgery [42], whereas
Figure 5. HSV1 invasion score and epithelial damage score.
Explants were inoculated with 1 ml 10
7 TCID50/ml HSV1 VR-733 and
sampled at different time points post inoculation (pi). Serial 20 mm
cryosections were made and evaluated. HSV1 mucosal invasion in the
depth was graded on a 6-point scale, as follows: 0=epithelium not
infected, 1=columnar cell(s) infected, 2=suprabasal cell(s) infected,
3=basal cell(s) infected, 4=basement membrane and HSV1 colocalisa-
tion, HSV1 does not cross the basement membrane, 5=HSV1
penetrates the basement membrane into the lamina propria. Epithelial
damage was graded on a 4-point scale, as follows: 0=no damage,
1=superficial damage, 2=epithelial damage involving basal cells, basal
epithelial cells partly detached, 3=epithelium severely damaged, loose.
Both scales were combined on the same axis. The scores represent the
mean of the scores of 10 different regions of HSV1-negative (100 cells)
and HSV1-positive (virus plaque) cells per person at 0, 12, 16, 20, 24 and
36 h post inoculation (pi); experiments were performed in triplicate.
Error bars indicate SD. *, Significant differences compared with the
control (HSV1-negative epithelium) at the 0.05 level.
doi:10.1371/journal.pone.0022160.g005
Table 3. Rate (%) of TUNEL-positive cells 6 SD in both the
epithelium and lamina propria of a region of HSV1-negative
and of a region of HSV1-positive cells (virus plaque) at 0, 12,
24 and 36 h post inoculation (pi).
% TUNEL-positive cells at … h pi
01 2 2 4 3 6
HSV1-negative
epithelium
0.660.1 0.660.2 1.260.4 0.660.1
HSV1-negative
lamina propria
1.060.1 0.960.4 1.060.3 1.260.6
HSV1-positive
epithelium
ND 0.060.0* 1.060.8 3.161.6*
HSV1-positive
lamina propria
ND ND 8.967.4 5.663.9
ND=not determined; no HSV1-positive cells were found.
* Significant differences compared with the control (HSV1-negative tissue) at
the 0.05 level.
doi:10.1371/journal.pone.0022160.t003
Table 4. Rate (%) of EMA-positive cells 6 SD in both the
epithelium and lamina propria of a region of HSV1-negative
and of a region of HSV1-positive cells (virus plaque) at 0, 12,
24 and 36 h post inoculation (pi).
% EMA-positive cells at … h pi
01 2 2 4 3 6
HSV1-negative
epithelium
0.460.1 0.360.2 0.460.2 0.360.2
HSV1-negative
lamina propria
0.460.3 0.760.5 0.560.5 0.360.1
HSV1-positive
epithelium
ND 0.861.4 1.260.3* 1.060.6
HSV1-positive
lamina propria
ND ND 0.160.2 0.560.5
ND=not determined; no HSV1-positive cells were found.
* Significant differences compared with the control (HSV1-negative tissue) at
the 0.05 level.
doi:10.1371/journal.pone.0022160.t004
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suffering from nasal obstruction resulting from nasal allergy
reached 210 mV [26]. As PD values differ with the physiopa-
thology of the nose, higher values were obtained for healthier
mucosa, we can speculate that our initial PD values might
correlate with healthy mucosa. More important is the fact that the
PD value did not noticeably change over the cultivation period.
Using FITC dextran as a molecular marker of tight junction intact
functionality, no time-dependent damage could be demonstrated.
Taken together, we can state that the functional integrity of the
explants was largely retained during cultivation with a slight
decrease in transmucosal electrical resistance.
The primary human nasal mucosa explants were susceptible to
infection with HSV1. Morphometric characteristics of the HSV1
mucosal invasion process have not been determined previously.
Using the explant model and a quantitative analysis system
described previously [43], kinetics of HSV1 mucosal spread were
determined by measuring evolution of plaque formation. HSV1
plaques were found to propagate in 3-dimensions and replication
was observed in both epithelium and underlying lamina propria.
HSV1 antigens were observed in the lamina propria from 16 h pi,
where the time frame of BM crossing was between 12 and 24 h pi.
All viral plaques had breached the BM at 24 h pi.
The viral crossing of the BM is consistent with observations
made for the porcine alphaherpesvirus, pseudorabies virus (PRV),
using the porcine model; viral spread through the BM evolved
similarly with increasing time pi [43]. However, some differences
were observed. Whereas PRV plaques show a distinct penetration
of the BM encompassing the entire radius of the viral plaque; HSV
plaques show a more limited, localized area of BM penetration,
which may correlate with the more pronounced respiratory
problems (mucopurulent nasal discharge) associated with PRV.
Similar observations were made for bovine herpesvirus type 1
[44]. Viral crossing of the BM has not been reported for equine
herpesvirus type 1, where plaques remain confined to the
epithelium [45].
Studies on HSV1 mucosal invasion in human tissue are limited.
Our observations for the first time unequivocally show that HSV1
has the capacity to breach the BM, where virus replication is found
in the lamina propia underneath the BM. Notwithstanding the
statement of Weeks et al. [22] that virus reaches the stroma via free
nerve endings, we postulate that virus must traverse the BM to
accomplish replication in the lamina propria, a position sustained
by the fact that nerve fibres are surrounded by a BM barrier once
they extend in the lamina propria [46]. The human nasal
respiratory explant model may provide a pivotal role in exploring
the mechanism of viral transport towards and through the BM. So
far, it remains elusive whether or not the virus can directly
manipulate host factors to facilitate taxis towards and penetration
of the BM. The explant model represents a readily available, easily
tractable and holistic tool to address these questions.
Effects of HSV1 infection on human nasal respiratory mucosa
were evaluated using an epithelial damage scoring system and by
performing a TUNEL assay and an EMA staining. It was shown
that epithelial cells were loosened with increasing time pi.
However, rounding up and detachment of HSV1-infected
epithelial cells was not accompanied by apoptosis or necrosis.
Only a few HSV1-positive cells were TUNEL- or EMA-positive,
even at 36 h pi, although a large amount of the epithelial cells
were HSV1-positive and showed the typical cytopathic effect.
However, we have to remark that at later time points pi, some
epithelial HSV1-infected cells were already lost. The amount of
HSV1-positive cells in the lamina propria that were TUNEL-
positive appeared to be higher, although not significantly, than in
the epithelium. Our data are in line with Esaki et al. [47], who
showed a large number of HSV-positive epithelial cells after
corneal inoculation of mice, with only a minority being TUNEL-
positive. In comparison, more TUNEL-positive cells were seen in
the stroma. Asano et al. [48] revealed that HSV-positive epithelial
cells remained TUNEL-negative after corneal infection of mice,
though epithelial swelling was noticed and changes in apoptosis
were observed in the connective tissue. Further along these lines,
Miles et al. [49] obtained corneas from 2 patients with herpes
simplex keratitis, where one infection was determined to be
quiescent, the other one acute. Viral- and TUNEL-positivity was
shown in epithelial cells in the acute infection and in stromal
keratocytes in the quiescent infection, which might indicate that
apoptosis does occur during HSV1 keratitis in humans. In this
study, no percentage of TUNEL-positive cells relative to HSV1-
infected cells was mentioned. Our data, derived during a primary
HSV1 infection in our explant model system, demonstrated very
low levels of apoptosis in HSV1-infected cells of both epithelium
and lamina propria.
Previously, it has been demonstrated that herpesviruses effect a
block in apoptosis during infection, playing a crucial role in viral
pathogenesis [47,50–51]. HSV1 encodes several proteins that
counteract HSV infection-induced apoptosis. US3, US5, US11,
ICP6 and the R1 subunit of HSV ribonucleotide reductase (LAT
RNA) are able to counteract apoptosis in the absence of other viral
functions [52–55]. Furthermore, ICP27 [56] and UL14 [57] are
also involved in suppression of apoptosis. Studies describing the
anti-apoptotic activity of these viral proteins were performed in
cultured human cells and rabbits. Increasing evidence indicates
that the effects, resulting from perturbations of the apoptotic
process are cell type- and stimulus-specific [58]. In support of this,
HSV1 was shown to block apoptosis in a cell-type-dependent
manner [59]. Therefore, it is most interesting to obtain more in
vivo data to understand the interaction between HSV and human
tissues and to determine whether HSV1 is able to suppress
apoptotic pathways in human tissues. Our current ex vivo data
indicate that the mechanisms employed by HSV1 to counteract
apoptosis are functional in nasal mucosal tissue.
Based on the limited number of TUNEL- or EMA-positive cells,
we speculate that anti-apoptotic and/or anti-necrotic functions of
HSV1 are active in nasal mucosa. Promoting epithelial cell survival
would ensure that virus can penetrate the BM and reach the lamina
propria before the epithelial cells become apoptotic and therefore,
would enhance the depth of mucosal invasion in the infection
process. The simultaneous rounding up of epithelial cells could
facilitate virus release in the surroudings. Moreover, epithelial
damage could play a role in promoting local bacterial infections.
In conclusion, an in vitro human nasal respiratory explant
model was characterised, enabling research on HSV1 mucosal
invasion. HSV1 was found to replicate both in epithelium and
underlying lamina propria. Apoptotic or necrotic effects did not
accompany the severe epithelial damage, which may underscore
the anti-apoptotic and/or anti-necrotic features of HSV1. The
evolution of HSV1 plaque formation was determined in 3-
dimensions. Our results for the first time directly demonstrate that
HSV1 penetrates the BM between 12 and 24 h pi. Future research
will be aimed at unraveling the mechanisms of HSV mucosal
invasion and BM passage. This research may lead to strategies,
which interfere with early steps of herpesvirus pathogenesis by
inhibiting stromal infection and therefore blocking mucosal
invasion, which may complement current antiviral drugs for
critical and sometimes life-threatening infections and offer
alternative therapeutic approaches in the case of infections with
resistant viruses.
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